期刊文献+

白细胞介素10和白细胞介素6在淋巴瘤中的表达及其意义

Significance of IL-IO and IL-6 expression in lymphoma
原文传递
导出
摘要 目的探讨白细胞介素(IL)-10和IL-6在不同类型淋巴瘤组织与血浆中的表达及其意义。方法收集97例淋巴瘤患者石蜡组织和血浆标本,应用免疫组织化学和酶联免疫吸附试验(ELISA)的方法观察组织与血浆中IL-10和IL-6表达情况。结果IL-10和IL-6在不同类型淋巴瘤组织中皆呈阳性表达,且各亚型之间差异无统计学意义(x2=0.815,x2=0.542,均P〉0.05);IL-10和IL-6分别在肿瘤中的巨噬细胞和血管内皮细胞也有不同程度的阳性表达。淋巴瘤患者血浆IL-10和IL-6水平[(232.57±191.59)pg/ml、(80.70±89.68)Pg/ml]高于健康对照组[(59.12±68.35)Pg/ml、(45.68±33.66)pg/ml],差异有统计学意义(t=6.968,t=2.896,P〈0.05);血浆IL-10和IL-6水平随肿瘤细胞表达强度增强而增强(x2=0.815,x2=0.542,P〈0.05);IL-10和IL-6在淋巴瘤细胞表达强度两者呈正相关(L=0.394,P〈0.05)。结论IL-10和IL-6在淋巴瘤患者淋巴瘤组织和血浆中都有表达,淋巴瘤患者血浆IL—10和IL-6水平高于健康对照组,二者在淋巴瘤的发生、发展中起着一定的作用,可能作为淋巴瘤诊断的辅助指标。 Objective To investigate the expression of IL-10 and IL-6 in tissue and plasma of subtypes lymphoma and its significance. Methods Immunohistochemical technique and enzyme-linked immunosorbent assay (ELISA) were used to assess the expression of IL-10 and IL-6 in 97 cases paraffin tissue and plasma samples from different subtypes of lymphoma. Results Expression of IL-10 and IL-6 was positive in all lymphoma tissue samples, but there is no significant difference among different subtypes lymphoma (x2 = 0.815, X2 = 0.542, P 〉 0.05). Tumor samples were found positive IL-10 and IL-6 expression in macrophages and vascular endothelial cells by immunohistochemistry respectively. Expression of IL-10 and IL-6 in plasma of lymphoma were higher than that in control respectively [(232.57±191.59) pg/ml vs (59.12± 68.35) pg/ml, (80.70±89.68) pg/ml vs (45.68±33.66) pg/ml], with significant difference (t = 6.968, t = 2.896, P 〈0.05). IL-10 and IL-6 plasma levels increased with enhanced expression in lymphoma (X2 = 0.815, X2 = 0.542, P 〈 0.05). Which was found to be correlated with each other (r, = 0.394, P 〈 0.05). Conclusion The expression of IL-10 and IL-6 had been found at various degrees in tissues and plasma of lymphoma. IL-10 and IL-6 in plasma of lymphoma were higher than that in controls. These results showed that IL-10 and IL-6 may cooperate in vivo with lymphoma cell proliferation and infiltrate. IL-6 and IL-10 maybe served as useful indicators for diagnosis of lymphoma.
出处 《白血病.淋巴瘤》 CAS 2012年第1期50-53,共4页 Journal of Leukemia & Lymphoma
基金 基金项目:国家自然科学基金(30860096)
关键词 淋巴瘤 白细胞介素10 白细胞介素6 免疫组织化学 酶联免疫吸附测定 Lymphoma Interleukin-10 Interleukin-6 Immunohistochemistry Enzyme-Linked immunosorbent assay
  • 相关文献

参考文献18

  • 1Voorzanger N,Touitou R,Garcia E,et al.Interleukin IL-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.Cancer Res,1996,11:5499-5505.
  • 2Heikkil(a) K, Ebrahim S, Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer.Eur J Cancer,2008,44:937-945.
  • 3Nishihira K,Imamkra T,Yamashita A,et al.Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy.Eur Heart J,2006,27:1685-1689.
  • 4Jaffy ES, Harris NL, Stein H, et al. World health organization classification of tumours pathology and genetics of tumors of hematopoietic and lymphoid tissues.Lyon:IARC Press, 2008: 111-113.
  • 5张雅青,王秋兰.非霍奇金淋巴瘤中MMP-9与IL-6的表达与预后的关系[J].第四军医大学学报,2007,28(6):557-559. 被引量:2
  • 6Buhl L, Sφgaard H. Immunohistochemical expression of IL-10 in mycosis fungicides.Exp Dermatol,1997,6:195-198.
  • 7顾霞,林汉良.不同类型淋巴瘤Survivin的表达及其意义[J].癌症,2004,23(6):655-661. 被引量:18
  • 8Zeni E, Mazzetti L, Miotto D, et al. Macrophage expression of interleukin-10 is a prognostic factor in non small cell lung cancer.Eur Respir J,2007,30:627-632.
  • 9Urosevic M,Willers J,Mueller B,et al.HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10expression in large cell T-cell lymphomas and indolent B-cell lymphomas.Blood,2002,99:609-617.
  • 10El-Far M,Fouda M,Yahya R,et al.SerumIL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin's lymphoma.J Physiol Biochem,2004,60:253-258.

二级参考文献23

  • 1刘艳波,蔡莲莲,王宗敏,赵志光.白细胞介素6在子宫颈癌组织中的表达及其与血管生成的关系[J].中华妇产科杂志,2005,40(3):197-199. 被引量:11
  • 2Narris D A. Immune mechanism in cutaneous disease[M]. New York:Marcel Dekker, 1989:46.
  • 3张风蕴.炎性因子.国外医学:免疫学分册,1992,82:479-492.
  • 4Takai N, Miyazaki T, Nishida M, et al. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma [J]. Cancer Lett, 2002,184(1): 105 - 116.
  • 5Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma [ J ]. Br J Cancer, 2003,88 ( 1 ): 115 - 119.
  • 6Moriai R, Asanuma K, Kobayashi D, et al. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells [ J ]. Anticancer Res, 2001,21 ( 1 B): 595 - 600.
  • 7Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma [J]. Nat Med, 1997,3(8): 917 -921.
  • 8Nasu S, Yagihashi A, Izawa A, et al. Survivin mRNA expression in patients breast cancer [J]. Anticancer Res, 2002,22(3): 1839 -1843.
  • 9Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis [J] . Cancer, 2001, 91 (11 ):2026 - 2032.
  • 10Chakravarti A, Noll E, Block PM, et al. Quantitatively determined survivin expression level are of prognotic value in human gliomas [J]. J Clin Oncol, 2002,20(4): 1063 -1068.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部